Phil Marsh - Benzinga

SPY774.22+0.67%QQQ727.03+1.31%BTC/USD84,481.80+1.86%DIA527.34+0.57%GLD379.34+0.45%TLT80.24+0.14%

Articles by Phil Marsh

Sterne Agee Raises Estimates and Increases EPS Guidance for Destination Maternity Corp.

Sterne Agee Raises Estimates and Increases EPS Guidance for Destination Maternity Corp.

Sterne Agee Reports CIT Group to Pay More Debt

Sterne Agee Reports CIT Group to Pay More Debt

Sterne Agee Adjusts Estimates on SemiLEDS, Reiterates Buy Rating

Sterne Agee Adjusts Estimates on SemiLEDS, Reiterates Buy Rating

Sterne Agee Revises OCZ Technology Group's Estimates

Sterne Agee Revises OCZ Technology Group's Estimates

Benzinga's Cash Generator Gives 46.42% Return on Google

Benzinga's Cash Generator Gives 46.42% Return on Google

Auriga Maintains Buy, $125 Target on Deckers Outdoor

Auriga Maintains Buy, $125 Target on Deckers Outdoor

Auriga Reiterates Buy, $95 Target on McKesson

Auriga Reiterates Buy, $95 Target on McKesson

UPDATE: Auriga Upgrades EZchip to Buy, Raises PT to $37

UPDATE: Auriga Upgrades EZchip to Buy, Raises PT to $37

UPDATE: Auriga Reiterates Hold, Lowers Target to $48 on Columbia Sportswear

UPDATE: Auriga Reiterates Hold, Lowers Target to $48 on Columbia Sportswear

Oppenheimer Reiterates Perform on Citrix

Oppenheimer Reiterates Perform on Citrix

Oppenheimer Maintains Perform on NeuStar

Oppenheimer Maintains Perform on NeuStar

Oppenheimer Reiterates Outperform on BMC Software

Oppenheimer Reiterates Outperform on BMC Software

Oppenheimer Reiterates Outperform on CA

Oppenheimer Reiterates Outperform on CA

Wells Fargo Maintains Outperform, $86-88 Range on Edwards Lifesciences

Wells Fargo Maintains Outperform, $86-88 Range on Edwards Lifesciences

Stifel Nicolaus Reiterates Buy, $75 Target on Athenahealth

Stifel Nicolaus Reiterates Buy, $75 Target on Athenahealth

UPDATE: Stifel Nicolaus Reiterates Buy, Lowers PT to $54 on Raytheon

UPDATE: Stifel Nicolaus Reiterates Buy, Lowers PT to $54 on Raytheon

UPDATE: Stifel Nicolaus Reiterates Buy, Raises PT to $108 on Nike

UPDATE: Stifel Nicolaus Reiterates Buy, Raises PT to $108 on Nike

Stifel Nicolaus Initiates Sell on Nuveen Maryland Dividend Advantage Municipal Fund

Stifel Nicolaus Initiates Sell on Nuveen Maryland Dividend Advantage Municipal Fund

UPDATE: Stifel Nicolaus Initiates Hold on Nuveen Arizona Premium Income Municipal Fund

UPDATE: Stifel Nicolaus Initiates Hold on Nuveen Arizona Premium Income Municipal Fund

UPDATE: Stifel Nicolaus Initiates Sell on Nuveen Arizona Dividend Advantage

UPDATE: Stifel Nicolaus Initiates Sell on Nuveen Arizona Dividend Advantage